Statistics for Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer
Total visits
views | |
---|---|
Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer | 1 |
Total visits per month
views | |
---|---|
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
File Visits
views | |
---|---|
Targeting HIF1-alphamiR-326ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer.pdf | 55 |
Top country views
views | |
---|---|
United States | 1 |
Top city views
views | |
---|---|
Boardman | 1 |